Dividend investors would be wise to focus not just on a stock's current yield, but also on the long-term growth potential of its dividends. That's because strong businesses that consistently raise their dividend payouts reward shareholders with a steadily rising income stream that essentially equates to a raise every year. And, well, who doesn't like a raise?
But there are other reasons to value dividend growth so highly, and they're well supported by research. For instance, a study by C. Thomas Howard published in Advisor Perspectives found that for every percentage point a stock's yield rises, its annual return increases by 0.22 percentage points if it's a large cap, 0.25 if it's a mid cap, and 0.46 if it's a small cap. Even better, Howard found that dividend-growing stocks outperformed dividend cutters by 10 percentage points per year from 1973 to 2010 and beat both flat- and no-dividend stocks. And the icing on the cake is that Howard showed that this outperformance came with a third less volatility. Higher returns, less volatility-induced stress, and a steadily growing income stream -- what's not to love?
5 Best Rising Stocks To Watch For 2015: Renesola Ltd.(SOL)
ReneSola Ltd, together with its subsidiaries, engages in the manufacture and sale of solar wafers and solar power products. It offers virgin polysilicons, monocrystalline and multicrystalline solar wafers, and photovoltaic cells and modules. The company also provides cell and module processing services. Its products are used in a range of residential, commercial, industrial, and other solar power generation systems. The company sells its solar wafers primarily to solar cell and module manufacturers. It principally operates in Mainland China, Singapore, Taiwan, Hong Kong, Korea, India, Australia, Germany, Italy, Spain, Belgium, France, the Czech Republic, and the United States. The company was founded in 2003 and is based in Jiashan, the People?s Republic of China.
Advisors' Opinion:- [By Aaron Levitt]
After years of cheap natural gas eating photovoltaic�� lunch, solar stocks are back with a vengeance. Already, we��e seen better earnings from a host of hot solar stocks like First Solar (FSLR) and Canadian Solar (CSIQ). And now, its smaller solar stock ReneSola�� turn (SOL) … and SOL stock may just surprise investors.
- [By Rich Duprey]
Photovoltaic module and wafer manufacturer ReneSola (NYSE: SOL ) has been contracted to�provide 7,200 250-watt high-efficiency polycrystalline solar PV modules for a project in Roswell, N.M.
- [By Dan Caplinger]
But Trina gave a troubling update to its quarterly guidance a couple weeks ago, saying that it shipped 390-400 megawatts of solar modules during the quarter, down from its original 420-430 megawatt estimate. With gross margins of just 1% to 3%, Trina isn't faring as badly as peer ReneSola (NYSE: SOL ) , which posted negative gross margins in its quarterly report earlier this month. Yet Trina still isn't making enough money to come close to profitability in the near future.
- [By James Brumley]
Which solar power stocks are the proverbial picks of the litter, though? Here are the first five a newcomer might want to consider.
ReneSola Ltd. (SOL)While most solar stocks have done incredibly well so far in 2014, ReneSola (SOL) wasn’t one of them. In fact, SOL stock is a bit unusual in that it’s trading well under its October high of $6 per share. That’s not a bad thing, though. In fact, it may work to your advantage because it gives new buyers a chance to scoop up ReneSola shares at a bargain price before their next big run-up.
5 Best Mid Cap Stocks To Invest In Right Now: United States Natural Gas Fund LP (UNG)
United States Natural Gas Fund, LP (USNG) is a limited partnership. The Company is a commodity pool that issues limited partnership interests (units) traded on the NYSE Arca, Inc. (the NYSE Arca). The investment objective of USNG is for the changes in percentage terms of its units��net asset value (NAV) to reflect the changes in percentage terms of the spot price of natural gas delivered at the Henry Hub, Louisiana as measured by the changes in the Futures Contract on natural gas traded on the New York Mercantile Exchange (NYMEX) that is the near month contract to expire, except when the near month contract is within two weeks of expiration, in which case the futures contract will be the next month contract to expire. The Company�� general partner is United States Commodity Funds LLC (the General Partner) and is responsible for the management of USNG.
USNG invests in futures contracts for natural gas, crude oil, heating oil, gasoline, and other petroleum-based fuels that are traded on the NYMEX, ICE Futures or other United States and foreign exchanges (collectively, Futures Contracts). USNG also invests in other natural gas-related investments, such as cash-settled options on Futures Contracts, forward contracts for natural gas, cleared swap contracts, and over-the-counter transactions that are based on the price of natural gas, oil and other petroleum-based fuels, Futures Contracts and indices based on the foregoing (collectively, Other Natural Gas-Related Investments). USNG invests in Natural Gas Interests to the fullest extent possible. In pursuing this objective, the primary focus of the General Partner is the investment in Futures Contracts and the management of USNG�� investments in short-term obligations of the United States of two years or less (Treasuries), cash and/or cash equivalents for margining purposes and as collateral.
Advisors' Opinion:- [By Matthew McCall]
United States Natural Gas ETF (NYSE: UNG)
The cold weather continues to grip the Northeast and natural gas prices remain high. UNG pulled back to support at the $23.50 area this week before beginning to attract buyers again. The ETF was up 2.7 percent Thursday and closed at a new one-week high as volume picked up. Technically the chart is suggesting the ETF could continue its run to the $26 area based on the recent action.
5 Best Mid Cap Stocks To Invest In Right Now: Cytokinetics Incorporated(CYTK)
Cytokinetics, Incorporated, a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics that modulate muscle function for the potential treatment of serious diseases and medical conditions. It primarily offers omecamtiv mecarbil, a cardiac muscle myosin activator, which is in Phase I/IIa clinical trials for the treatment of heart failure; CK-2017357, which is a Phase IIa clinical trials for the treatment of amyotrophic lateral sclerosis; and CK-2066260, a fast skeletal muscle sarcomere activator for the treatment of diseases and conditions associated with muscle weakness or wasting. The company?s cancer treatment products under development stage comprise ispinesib, SB-743921, and GSK-923295. It has a strategic alliance with Amgen Inc. to discover, develop, and commercialize novel small molecule therapeutics that activate cardiac muscle contractility for applications in the treatment of heart failure. The company was founded in 1997 and is headquartered in South San Francisco, California.
Advisors' Opinion:- [By Sean Williams]
What: Shares of Cytokinetics (NASDAQ: CYTK ) , a clinical-stage biopharmaceutical company focused on developing therapies for serious diseases, tanked as much as 38% after reporting mid-stage top-line data from acute heart failure drug, omecamtiv mecarbil.
- [By Brian Pacampara]
Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, clinical-stage biopharmaceutical company Cytokinetics (NASDAQ: CYTK ) has received a distressing two-star ranking.
- [By Rick Munarriz]
Tuesday
Cytokinetics (NASDAQ: CYTK ) checks in on Tuesday. The biotech company's lead candidate is a cardiac muscle contractility program that Cytokinetics is trying to get approved for the potential treatment of heart failure. Investors see red ink here, but analysts do see the quarterly deficit narrowing this time around.
5 Best Mid Cap Stocks To Invest In Right Now: DRDGOLD Ltd (DRD)
DRDGOLD Limited (DRDGOLD), incorporated on February 16, 1895, is a South Africa-based surface gold retreatment company. DRDGOLD operates in a single segment, Ergo. Ergo is a surface retreatment operation and treats old slime and sand dumps to the south of Johannesburg�� central business district, as well as the east and central Rand goldfields. The operation consists of four plants: Brakpan, Crown, City and Knights. Included in the Ergo segment is the East Rand Proprietary Mines Limited (ERPM) surface operation comprise the Cason retreatment operation. Ergo is evaluating the viability of processing surface uranium- and sulphur-bearing tailings on the east and central Rand goldfields of South Africa. The Company�� business includes Crown Gold Recoveries (Pty) Limited (Crown), Ergo Mining (Pty) Limited (Ergo JV) and ErgoGold are jointly referred to as ERGO and ERPM. On June 1, 2012, the Company disposed of its 74% interest in and loan claims against Blyvoor.
The Company�� focus is on the recovery of lower-risk, lower-cost, higher-margin ounces. As of October 9, 2012, 68% of production comes from surface retreatment operation. The company holds a 74%-interest in operating subsidiary Ergo Mining Operations (Proprietary) Limited. Crown is the gold surface tailings retreatment facility, reprocessing the large and numerous sand and slimes dumps along the reefs that stretch from east to west just to the south of Johannesburg�� central business district (CBD). Crown�� major project is Top Star, a tailings dam to the south of Johannesburg�� CBD. ERPM is situated on the Witwatersrand Basin near the town of Boksburg, 25 kilometers to the east of Johannesburg. The Ergo as a joint venture between DRDGOLD and Mintails Limited. Wholly owned by the DRDGOLD group, Ergo has a network of surface rights that provide access to a further 600 million tons of surface tailings deposited across the western, central and eastern Witwatesrand. Ergo has three tailings deposition facilities. ERPM continues ! as a surface retreatment operation. It holds 65% of ErgoGold through the contribution of its Elsburg Tailings Complex.
Advisors' Opinion:- [By Roland Head]
DRDGold (NYSE: DRD ) climbed 4.2% to $6.25 last week. Rather than mining gold, this South African firm is focused on large-scale reprocessing of the tailings, or waste piles, of large gold mines in order to extract the gold that was not captured by the original mining process. This business is heavily mechanized and requires a relatively small workforce, giving DRDGold some protection from the rising labor costs that are reducing the profitability of many South African mining firms.
- [By Maria Levitov]
The MSCI Emerging Markets Index added 0.3 percent to 1,033.97, after jumping to the highest level in five months yesterday. AngloGold Ashanti Ltd. and DRDGold Ltd. (DRD) drove South Africa�� benchmark equity index to a record, while the Philippine Stock Exchange Index led gains among developing-nation gauges. Russia�� Micex Index (INDEXCF) slumped 1.3 percent as oil companies plunged. The real strengthened on speculation Brazil�� central bank will raise its target rate next month.
No comments:
Post a Comment